This work is licensed under a Creative Commons Attribution 4.0 International License.
c1
General Information
DRACP ID DRACP00434
Peptide Name c1
Sequence KKWXWKK
Sequence Length 7
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| Ramos | Burkitt lymphoma; Burkitt lymphoma | Lymphoma | IC50=10±2 μM | MTT assay | Not available | 1 |
| Ramos | Burkitt lymphoma; Burkitt lymphoma | Lymphoma | IC50=22±5 μM | MTT assay | Not available | 1 |
Hemolytic Activity Human red blood cells: EC50=87 μM
Normal (non-cancerous) Cytotoxicity MRC-5: IC50=10±1 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond NCB: Lys1<--->Lys7
N-terminal Modification lactam
C-terminal Modification lactam
Other Modification X=β2,2(2-Nal-CH2-)=(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)
Chiral L
Physicochemical Information
Formula C46H68N12O6
Absent amino acids ACDEFGHILMNPQRSTVY
Common amino acids K
Mass 110232
Pl 11.28
Basic residues 4
Acidic residues 0
Hydrophobic residues 2
Net charge 4
Boman Index -1754
Hydrophobicity -248.57
Aliphatic Index 0
Half Life
/
Extinction Coefficient cystines 11000
Absorbance 280nm 1833.33
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22933412
Title Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid
Doi 10.1002/psc.2441
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.